This study analyzes the visual outcomes and rate of intraoperative complications of phacoemulsification surgery after prior pars plana vitrectomy. Source: AAO
This mouse study explored whether etanercept, a tumor necrosis factor inhibitor, can protect retinal ganglion cells and improve visual outcomes after optic nerve trauma. Source: AAO
This cross-sectional study compares the use of standard OCT with OCT angiography (OCT-A) for evaluating patients with glaucoma. Source: AAO
Sun Pharmaceuticals announced the approval of their preservative-free nanomicellar formulation of cyclosporine A for increasing tear production in patients with dry eye disease. Source: AAO
This cluster-randomized, intervention-controlled study examined the effect of a school-based program encouraging outdoor activities on myopia. Source: AAO
DeepMind plans to unleash an artificial intelligence product capable of diagnosing 50 ophthalmic conditions from a simple OCT scan, the company reports. Source: AAO
This week, retinal thinning heralds the onset of Parkinson’s disease, a piezo-print technology dots the cornea with a miniscule amount of latanoprost and sheep with achromatopsia wake up to good news about the benefits of CNGA3 gene therapy. Source: AAO
This study compares the efficacy and safety of intravitreous ranibizumab versus panretinal photocoagulation over 5 years of treatment in patients with proliferative diabetic retinopathy. Source: AAO
Researchers assessed the efficacy of oral voriconazole for treating filamentous fungal keratitis. Source: AAO
The FDA has approved the use of the Hydrus microstent in conjunction with cataract surgery to reduce IOP in patients with mild to moderate primary open-angle glaucoma. Source: AAO